Patents by Inventor Phillip GAUGER

Phillip GAUGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250073330
    Abstract: The present invention is directed to novel nucleotide and amino acid sequences of Porcine Epidemic Diarrhea Virus (“PEDV”), including novel genotypes thereof, all of which are useful in the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine PEDV genotypes and isolates. Diagnostic and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention, as are infectious clones useful in the propagation of the virus and in the preparation of vaccines. Particularly important aspects of the invention include polynucleotide constructs that replicate in tissue culture and in host swine. The invention also provides for novel full length PEDV genomes that can replicate efficiently in host animals and tissue culture.
    Type: Application
    Filed: May 10, 2024
    Publication date: March 6, 2025
    Inventors: Jianqiang ZHANG, Qi CHEN, Phillip GAUGER, Darin MADSON, John Morgan HARDHAM, Meggan BANDRICK, Jay Gregory CALVERT, James Richard THOMPSON, Mira Ivanova STOEVA, Walter VALDEZ
  • Patent number: 12005113
    Abstract: The present invention is directed to novel nucleotide and amino acid sequences of Porcine Epidemic Diarrhea Virus (“PEDV”), including novel genotypes thereof, all of which are useful in the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine PEDV genotypes and isolates. Diagnostic and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention, as are infectious clones useful in the propagation of the virus and in the preparation of vaccines. Particularly important aspects of the invention include polynucleotide constructs that replicate in tissue culture and in host swine. The invention also provides for novel full length PEDV genomes that can replicate efficiently in host animals and tissue culture.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: June 11, 2024
    Assignees: Zoetis Services LLC, Iowa State University Research Foundation, Inc.
    Inventors: Jianqiang Zhang, Qi Chen, Phillip Gauger, Darin Madson, John Morgan Hardham, Meggan Bandrick, Jay Gregory Calvert, James Richard Thompson, Mira Ivanova Stoeva, Walter Valdez
  • Publication number: 20220088179
    Abstract: The present invention is directed to novel nucleotide and amino acid sequences of Porcine Epidemic Diarrhea Virus (“PEDV”), including novel genotypes thereof, all of which are useful in the preparation of vaccines for treating and preventing diseases in swine and other animals Vaccines provided according to the practice of the invention are effective against multiple swine PEDV genotypes and isolates. Diagnostic and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention, as are infectious clones useful in the propagation of the virus and in the preparation of vaccines. Particularly important aspects of the invention include polynucleotide constructs that replicate in tissue culture and in host swine. The invention also provides for novel full length PEDV genomes that can replicate efficiently in host animals and tissue culture.
    Type: Application
    Filed: September 15, 2020
    Publication date: March 24, 2022
    Inventors: Jianqiang ZHANG, Qi CHEN, Phillip GAUGER, Darin MADSON, John Morgan HARDHAM, Meggan BANDRICK, Jay Gregory CALVERT, James Richard THOMPSON, Mira Ivanova STOEVA, Walter VALDEZ
  • Patent number: 11124777
    Abstract: The present invention is directed to novel nucleotide and amino acid sequences of Porcine Sapelovirus (“PSV”), including novel genotypes thereof, all of which are useful in the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine PSV genotypes and isolates. Diagnostic and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention, as are infectious clones useful in the propagation of the virus and in the preparation of vaccines. Particularly important aspects of the invention include polynucleotide constructs that replicate in tissue culture and in host swine. The invention also provides for novel full-length PSV genomes that can replicate efficiently in host animals and tissue culture.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: September 21, 2021
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Qi Chen, Bailey Arruda, Kent Schwartz, Phillip Gauger, Jianqiang Zhang
  • Patent number: 11058763
    Abstract: The present invention is directed to novel nucleotide and amino acid sequences of Porcine Epidemic Diarrhea Virus (“PEDV”), including novel genotypes thereof, all of which are useful in the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine PEDV genotypes and isolates. Diagnostic and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention, as are infectious clones useful in the propagation of the virus and in the preparation of vaccines. Particularly important aspects of the invention include polynucleotide constructs that replicate in tissue culture and in host swine. The invention also provides for novel full length PEDV genomes that can replicate efficiently in host animals and tissue culture.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: July 13, 2021
    Assignees: Zoetis Services LLC, Iowa State University Research Foundation, Inc.
    Inventors: Jianqiang Zhang, Qi Chen, Phillip Gauger, Darin Madson, John Morgan Hardham, Meggan Bandrick, Jay Gregory Calvert, James Richard Thompson, Mira Ivanova Stoeva, Walter Valdez
  • Patent number: 11013796
    Abstract: The present invention is directed to novel nucleotide and amino acid sequences of Porcine Parainfluenza Virus Type 1 (“PPIV-1”), including novel genotypes thereof, all of which are useful in the preparation of immunogenic compositions and vaccines for treating and preventing disease in swine.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: May 25, 2021
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Phillip Gauger, Jie Yeun Park, Karen M. Harmon, Jianqiang Zhang, Pablo Pineyro
  • Publication number: 20200172878
    Abstract: The present invention is directed to novel nucleotide and amino acid sequences of Porcine Sapelovirus (“PSV”), including novel genotypes thereof, all of which are useful in the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine PSV genotypes and isolates. Diagnostic and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention, as are infectious clones useful in the propagation of the virus and in the preparation of vaccines. Particularly important aspects of the invention include polynucleotide constructs that replicate in tissue culture and in host swine. The invention also provides for novel full-length PSV genomes that can replicate efficiently in host animals and tissue culture.
    Type: Application
    Filed: December 3, 2019
    Publication date: June 4, 2020
    Inventors: Qi Chen, Bailey Arruda, Kent Schwartz, Phillip Gauger, Jianqiang Zhang
  • Publication number: 20200069789
    Abstract: The present invention is directed to novel nucleotide and amino acid sequences of Porcine Parainfluenza Virus Type 1 (“PPIV-1”), including novel genotypes thereof, all of which are useful in the preparation of immunogenic compositions and vaccines for treating and preventing disease in swine.
    Type: Application
    Filed: August 30, 2019
    Publication date: March 5, 2020
    Inventors: Phillip Gauger, Jie Yeun Park, Karen M. Harmon, Jianqiang Zhang, Pablo Pineyro
  • Publication number: 20180064804
    Abstract: The present invention is directed to novel nucleotide and amino acid sequences of Porcine Epidemic Diarrhea Virus (“PEDV”), including novel genotypes thereof, all of which are useful in the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine PEDV genotypes and isolates. Diagnostic and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention, as are infectious clones useful in the propagation of the virus and in the preparation of vaccines. Particularly important aspects of the invention include polynucleotide constructs that replicate in tissue culture and in host swine. The invention also provides for novel full length PEDV genomes that can replicate efficiently in host animals and tissue culture.
    Type: Application
    Filed: February 26, 2016
    Publication date: March 8, 2018
    Inventors: Jianqiang ZHANG, Qi CHEN, Phillip GAUGER, Darin MADSON, John Morgan HARDHAM, Meggan BANDRICK, Jay Gregory CALVERT, James Richard THOMPSON, Mira Ivanova STOEVA, Walter VALDEZ